Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Mar;105(3):557–562. doi: 10.1111/j.1476-5381.1992.tb09018.x

Impaired endothelium-dependent relaxation of dog coronary arteries after myocardial ischaemia and reperfusion: prevention by amlodipine, propranolol and allopurinol.

C G Sobey 1, R A Dalipram 1, G J Dusting 1, O L Woodman 1
PMCID: PMC1908435  PMID: 1385750

Abstract

1. Anaesthetized, open-chest dogs were subjected to 60 min of left circumflex coronary artery occlusion followed by 90 min of reperfusion. Endothelium-dependent and -independent relaxant responses of the isolated coronary arterial rings were then investigated. 2. The endothelium-dependent, acetylcholine-induced relaxation of ischaemic/reperfused arterial rings was significantly attenuated in comparison to control rings (1.9 fold rightward shift, ischaemic/reperfused maximum relaxation = 57 +/- 13% of control maximum relaxation; P less than 0.05). In contrast, glyceryl trinitrate produced similar relaxant responses in control and ischaemic rings. 3. Pretreatment of dogs with either amlodipine (3 micrograms kg-1 min-1, i.v.) or propranolol (1 mg kg-1, i.v.) completely prevented the postischaemic impairment of endothelium-dependent relaxant responses (100 +/- 3% and 90 +/- 5% of control maximum relaxation, respectively). 4. Allopurinol pretreatment (25 mg kg-1, p.o. 24 h previously, plus 50 mg kg-1 i.v. 5 min before arterial occlusion) partially protected against endothelial dysfunction by preventing the ischaemia-induced rightward shift of the acetylcholine relaxation curve and increasing the maximum relaxation response (83 +/- 7% of control rings). 5. These results confirm that endothelium-dependent coronary vascular relaxation is impaired by ischaemia and reperfusion, and that the ischaemia-induced impairment is reduced by pretreatment with amlodipine, propranolol or allopurinol.

Full text

PDF
557

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrosio G., Becker L. C., Hutchins G. M., Weisman H. F., Weisfeldt M. L. Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury. Circulation. 1986 Dec;74(6):1424–1433. doi: 10.1161/01.cir.74.6.1424. [DOI] [PubMed] [Google Scholar]
  2. Armiger L. C., Gavin J. B. Changes in the microvasculature of ischemic and infarcted myocardium. Lab Invest. 1975 Jul;33(1):51–56. [PubMed] [Google Scholar]
  3. Chambers D. J., Braimbridge M. V., Hearse D. J. Free radicals and cardioplegia: allopurinol and oxypurinol reduce myocardial injury following ischemic arrest. Ann Thorac Surg. 1987 Sep;44(3):291–297. doi: 10.1016/s0003-4975(10)62076-0. [DOI] [PubMed] [Google Scholar]
  4. Engler R. L., Schmid-Schönbein G. W., Pavelec R. S. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol. 1983 Apr;111(1):98–111. [PMC free article] [PubMed] [Google Scholar]
  5. Gillespie M. N., Kojima S., Kunitomo M., Jay M. Coronary and myocardial effects of activated neutrophils in perfused rabbit hearts. J Pharmacol Exp Ther. 1986 Dec;239(3):836–840. [PubMed] [Google Scholar]
  6. Ichihara K., Abiko Y. Effects of diltiazem and propranolol on irreversibility of ischemic cardiac function and metabolism in the isolated perfused rat heart. J Cardiovasc Pharmacol. 1983 Sep-Oct;5(5):745–751. doi: 10.1097/00005344-198309000-00007. [DOI] [PubMed] [Google Scholar]
  7. Irita K., Fujita I., Takeshige K., Minakami S., Yoshitake J. Calcium channel antagonist induced inhibition of superoxide production in human neutrophils. Mechanisms independent of antagonizing calcium influx. Biochem Pharmacol. 1986 Oct 15;35(20):3465–3471. doi: 10.1016/0006-2952(86)90613-1. [DOI] [PubMed] [Google Scholar]
  8. Jolly S. R., Kane W. J., Bailie M. B., Abrams G. D., Lucchesi B. R. Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res. 1984 Mar;54(3):277–285. doi: 10.1161/01.res.54.3.277. [DOI] [PubMed] [Google Scholar]
  9. Jouvin-Marche E., Cerrina J., Coëffier E., Duroux P., Benveniste J. Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and beta-glucuronidase from human neutrophils. Eur J Pharmacol. 1983 Apr 22;89(1-2):19–26. doi: 10.1016/0014-2999(83)90603-9. [DOI] [PubMed] [Google Scholar]
  10. Ku D. D. Coronary vascular reactivity after acute myocardial ischemia. Science. 1982 Nov 5;218(4572):576–578. doi: 10.1126/science.7123259. [DOI] [PubMed] [Google Scholar]
  11. Lu H. R., Vandeplassche G., Wouters L., Flameng W., Borgers M. Effects of beta-adrenoceptor antagonists on cardiac function in ischemic-reperfused myocardium of the isolated working rabbit heart. Eur J Pharmacol. 1990 Aug 2;184(1):65–74. doi: 10.1016/0014-2999(90)90667-u. [DOI] [PubMed] [Google Scholar]
  12. Lucchesi B. R., Burmeister W. E., Lomas T. E., Abrams G. D. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761). J Pharmacol Exp Ther. 1976 Nov;199(2):310–328. [PubMed] [Google Scholar]
  13. Lucchesi B. R., Mullane K. M. Leukocytes and ischemia-induced myocardial injury. Annu Rev Pharmacol Toxicol. 1986;26:201–224. doi: 10.1146/annurev.pa.26.040186.001221. [DOI] [PubMed] [Google Scholar]
  14. Mak I. T., Weglicki W. B. Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation. Circ Res. 1990 May;66(5):1449–1452. doi: 10.1161/01.res.66.5.1449. [DOI] [PubMed] [Google Scholar]
  15. Mak I. T., Weglicki W. B. Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circ Res. 1988 Jul;63(1):262–266. doi: 10.1161/01.res.63.1.262. [DOI] [PubMed] [Google Scholar]
  16. Mehta J. L., Lawson D. L., Nichols W. W. Attenuated coronary relaxation after reperfusion: effects of superoxide dismutase and TxA2 inhibitor U 63557A. Am J Physiol. 1989 Oct;257(4 Pt 2):H1240–H1246. doi: 10.1152/ajpheart.1989.257.4.H1240. [DOI] [PubMed] [Google Scholar]
  17. Mehta J. L., Nichols W. W., Donnelly W. H., Lawson D. L., Saldeen T. G. Impaired canine coronary vasodilator response to acetylcholine and bradykinin after occlusion-reperfusion. Circ Res. 1989 Jan;64(1):43–54. doi: 10.1161/01.res.64.1.43. [DOI] [PubMed] [Google Scholar]
  18. Mehta J. L., Nichols W. W., Donnelly W. H., Lawson D. L., Thompson L., ter Riet M., Saldeen T. G. Protection by superoxide dismutase from myocardial dysfunction and attenuation of vasodilator reserve after coronary occlusion and reperfusion in dog. Circ Res. 1989 Nov;65(5):1283–1295. doi: 10.1161/01.res.65.5.1283. [DOI] [PubMed] [Google Scholar]
  19. Mueller H. S., Ayres S. M., Religa A., Evans R. G. Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics. Circulation. 1974 Jun;49(6):1078–1087. doi: 10.1161/01.cir.49.6.1078. [DOI] [PubMed] [Google Scholar]
  20. Mullane K. M., Read N., Salmon J. A., Moncada S. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther. 1984 Feb;228(2):510–522. [PubMed] [Google Scholar]
  21. Muxfeldt M., Schaper W. The activity of xanthine oxidase in heart of pigs, guinea pigs, rabbits, rats, and humans. Basic Res Cardiol. 1987 Sep-Oct;82(5):486–492. doi: 10.1007/BF01907096. [DOI] [PubMed] [Google Scholar]
  22. Nayler W. G., Ferrari R., Williams A. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol. 1980 Aug;46(2):242–248. doi: 10.1016/0002-9149(80)90064-8. [DOI] [PubMed] [Google Scholar]
  23. Nishida M., Kuzuya T., Hoshida S., Kim Y., Kitabatake A., Kamada T., Tada M. Polymorphonuclear leukocytes induced vasoconstriction in isolated canine coronary arteries. Circ Res. 1990 Jan;66(1):253–258. doi: 10.1161/01.res.66.1.253. [DOI] [PubMed] [Google Scholar]
  24. Ogawa T., Sugiyama S., Hieda N., Ito T., Satake T., Ozawa T. Biochemical and morphological changes in myocardium during coronary occlusion and reperfusion in canine hearts: effects of propranolol on myocardial damage. Cardiovasc Res. 1989 May;23(5):417–423. doi: 10.1093/cvr/23.5.417. [DOI] [PubMed] [Google Scholar]
  25. Ohlstein E. H., Nichols A. J. Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Circ Res. 1989 Oct;65(4):917–924. doi: 10.1161/01.res.65.4.917. [DOI] [PubMed] [Google Scholar]
  26. Przyklenk K., Kloner R. A. "Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res. 1989 Jan;64(1):86–96. doi: 10.1161/01.res.64.1.86. [DOI] [PubMed] [Google Scholar]
  27. Romson J. L., Hook B. G., Kunkel S. L., Abrams G. D., Schork M. A., Lucchesi B. R. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 1983 May;67(5):1016–1023. doi: 10.1161/01.cir.67.5.1016. [DOI] [PubMed] [Google Scholar]
  28. Schrader J. Mechanisms of ischemic injury in the heart. Basic Res Cardiol. 1985;80 (Suppl 2):135–139. [PubMed] [Google Scholar]
  29. Sessa W. C., Mullane K. M. Release of a neutrophil-derived vasoconstrictor agent which augments platelet-induced contractions of blood vessels in vitro. Br J Pharmacol. 1990 Mar;99(3):553–559. doi: 10.1111/j.1476-5381.1990.tb12967.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Singh B. N. The mechanism of action of calcium antagonists relative to their clinical applications. Br J Clin Pharmacol. 1986;21 (Suppl 2):109S–121S. doi: 10.1111/j.1365-2125.1986.tb02860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tamura Y., Chi L. G., Driscoll E. M., Jr, Hoff P. T., Freeman B. A., Gallagher K. P., Lucchesi B. R. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart. Circ Res. 1988 Nov;63(5):944–959. doi: 10.1161/01.res.63.5.944. [DOI] [PubMed] [Google Scholar]
  32. VanBenthuysen K. M., McMurtry I. F., Horwitz L. D. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest. 1987 Jan;79(1):265–274. doi: 10.1172/JCI112793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Werns S. W., Shea M. J., Mitsos S. E., Dysko R. C., Fantone J. C., Schork M. A., Abrams G. D., Pitt B., Lucchesi B. R. Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart. Circulation. 1986 Mar;73(3):518–524. doi: 10.1161/01.cir.73.3.518. [DOI] [PubMed] [Google Scholar]
  34. Werns S. W., Simpson P. J., Mickelson J. K., Shea M. J., Pitt B., Lucchesi B. R. Sustained limitation by superoxide dismutase of canine myocardial injury due to regional ischemia followed by reperfusion. J Cardiovasc Pharmacol. 1988 Jan;11(1):36–44. doi: 10.1097/00005344-198801000-00006. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES